[
    [
        {
            "time": "",
            "original_text": "欧普康视持股5%以上股东减持198万股",
            "features": {
                "keywords": [
                    "欧普康视",
                    "持股5%以上",
                    "股东减持",
                    "198万股"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "欧普康视持股5%以上股东减持198万股",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 4,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "[优异评级] 医药生物行业研究简报：国务院机构改革方案亮相 注射剂研发技术指导意见发布",
            "features": {
                "keywords": [
                    "医药生物",
                    "国务院",
                    "机构改革",
                    "注射剂研发",
                    "技术指导意见"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[优异评级] 医药生物行业研究简报：国务院机构改革方案亮相 注射剂研发技术指导意见发布",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        }
    ]
]